|Articles|April 8, 2011

Testofen Male Libido Study Published

The double-blind, randomized, placebo-controlled trial performed on 60 healthy males without erectile dysfunction.

Gencor Nutrients Inc. (Anaheim, CA) announced that a human clinical study performed on its Testofen ingredient for healthy libido has been published in Phytotherapy Research.

The double-blind, randomized, placebo-controlled trial performed on 60 healthy males without erectile dysfunction found that a 600-mg dose of Testofen daily resulted in significant positive changes in sexual cognition, sexual arousal, sexual experience, and orgasm, and may assist in maintaining normal testosterone levels.

From ingredient science to consumer trends, get the insights you need to stay competitive in the nutrition industry. Subscribe to Nutritional Outlook today.

Testofen Male Libido Study Published

Related Content

Nature's Bounty Partners with SWHR to Close Women's Health Knowledge Gaps

Thorne Prenatal Supplement Earns NSF Certified for Sport Certification

OmniActive Launches Fenavari, a Combined Fenugreek-Shatavari Ingredient for Menopause Support

Performance Nutrition for Female Athletes: Beta-Alanine and Life-Stage Considerations

All G's LFX Brings Commercial-Scale Apo-Lactoferrin to the US Market

Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends

New Report Calls for Combined Sodium-Potassium Strategy in Hypertension Management

Ross Introduces 250-Gallon Retention Mixers for High-Pressure Processing

The Council for Responsible Nutrition Responds to NYT's AI Wellness Influencer Investigation

Study Finds Popular AI Calorie-Tracking Apps Underestimate Meal Energy by About a Third

Thorne Prenatal Supplement Earns NSF Certified for Sport Certification